Financial Institutions Inc (NASDAQ: FISI) has reported E.P.S. of $-4.02 for its fourth fiscal quarter (ending December 31) versus $0.61 for the same period a year ago — a decline of -759%. For the latest […]
Dover Corp (NYSE: DOV) has reported E.P.S. of $1.74 for its fourth fiscal quarter (ending December 31) versus $2.12 for the same period a year ago — a decline of -18%. For the latest four […]
Comcast Corp (NASDAQ: CMCSA) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.24 versus $0.81 for the same period a year ago — an increase of 53%. For the latest four […]
Civista Bancshares Inc (NASDAQ: CIVB) has reported E.P.S. of $0.63 for its fourth fiscal quarter (ending December 31) versus $0.62 for the same period a year ago — an increase of 2%. E.P.S. were $2.01 […]
For its third fiscal quarter (ending December 31), Cavco Industries Inc (NASDAQ: CVCO) has reported a 62% increase in E.P.S. from $4.31 a year ago to $6.97 in the current quarter. For the latest four […]
On 1/30/25, Cardiff Oncology Inc (NASDAQ: CRDF) stock enjoyed a major increase of 15.1%, closing at $3.97. However, this advance was accompanied by unusually low trading volume at 60% of normal. Relative to the market […]
Thermo Fisher Scientific Inc (NYSE: TMO) has reported earnings for its fourth fiscal quarter (ending December 31) of $4.79 versus $4.22 for the same period a year ago — an increase of 14%. For the […]
For its fourth fiscal quarter (ending December 31), SunCoke Energy Inc (NYSE: SXC) has reported a 75% increase in E.P.S. from $0.16 a year ago to $0.28 in the current quarter. E.P.S. were $1.13 for […]
Southwest Airlines Co. (NYSE: LUV) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.44 versus a loss $-0.42 for the same period a year ago — a decline of -205%. E.P.S. […]
For its fourth fiscal quarter (ending December 31), Quest Diagnostics Inc (NYSE: DGX) has reported a 15% increase in E.P.S. from $1.72 a year ago to $1.98 in the current quarter. For the latest four […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research